DE | EN

The effects of cannabis on Parkinson's disease

Medical cannabis is a legally approved therapy in Germany for patients with Parkinson’s disease, when previous therapies have been unsuccessful

420 Clinic > Cannabis-Wissen > Medical
Adrien Hingert • 7 Nov 2026

Medical effects cannabis parkinsons disease

Since 2017, medical cannabis has been legally approved in Germany as a possible therapeutic avenue for patients with severe symptoms of Parkinson’s disease when previous therapies have been unsuccessful or not tolerated, and a positive effect of cannabis on Parkinson’s disabling symptoms is imaginable.

Parkinson's disease, a debilitating disorder with insufficient treatment, is characterized by the progressive loss of dopamine-producing neurons. The resulting dopamine deficiency disrupts the circuits responsible for controlling movement, which contributes to tremor, muscle rigidity, slow movement and difficulties with walking and balance.

The endocannabinoid system is involved in regulating activity within these same brain circuits and cannabinoid receptors are abundant in several of these circuits. Their activation can change the release of neurotransmitters which influence movement. Researchers have therefore investigated whether cannabinoids could help regulate abnormal motor activity or alleviate non-motor symptoms such as anxiety, pain and disturbed sleep.

higher THC content does appear to provide more benefit, but with a higher risk of psychosis as a side effect when compared to CBD


A 2021 systematic review and meta-analysis in the Journal of Parkinson’s Disease covered five randomized controlled studies and eighteen non-randomized studies, and found no compelling evidence to recommend cannabis for people with Parkinson’s. This however indicated that many of the studies it analyzed were too short (lasting under 6 weeks, when at least 3 months would have been expected), and that the doses used were low compared to expectations because some participants did not attain the target treatment dose due to cannabis related adverse effects associated with THC.

The same review still identified a possible benefit for tremor, anxiety, pain, sleep quality and quality of life, and said better randomized studies are needed in these areas.

A 2020 study involving questionnaires sent to the German Parkinson Association with 1,348 responses indicated that there was an improvement of the symptoms reported by 54% of users applying oral CBD and 68% of users inhaling THC-containing cannabis. Additionally a reduction of pain and muscle cramps was reported by more than 40% of participants, while stiffness, freezing, tremor, depression, anxiety and restless legs syndrome subjectively improved for more than 20%.

The effects of cannabis on Parkinson's disease


Overall, uncontrolled studies look promising, but most placebo-controlled trials do not confirm a benefit.

Overall, from the evidence to date, higher THC content does appear to provide more benefit, but with a higher risk of psychosis as a side effect when compared to CBD. However, caution must be applied because there may be variability in the amount of THC/CBD ratio in any bought product due to lack of regulatory quality control of production.

Patients with cognitive impairment, behavioral disorders, orthostatic hypotension, or daytime sleepiness due to an increased risk of side effects are generally discouraged from medical cannabis therapies. Additionally, respiratory complications need to be taken into account with the use of inhaled cannabis products (vaping or smoking), especially for patients with pre-existing conditions.


Ähnliche Artikel
• Die Situation rund um den medizinischen und persönlichen Cannabiskonsum in Deutschland
• Die antiemetische Wirkung von Cannabis bei einer Chemotherapie
• So lagern Sie medizinisches Cannabis zu Hause